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Nimesulide, a non-steroidal anti-inflammatory drug (NSAID) of sulfonanilide class, has been
crystallized from solvents and by solvent change. Crystals have also been made by solvent change in the
presence of Tween 80 or Povidone K30 (PVP) or polyethylene glycol 4000 (pEG). Dissolution rate of
crystals has been evaluated in U.S.P. dissolution apparatus using phosphate buffer (PH 7.2) as the
dissolution fluid. Crystals having faster dissolution have been characterised by FTIR, XRD and DSC
analysis.Crystals prepared by solvent change (ethanol-water1:1) in the presence of Tween 80 (1%) provide
fastest dissolution followedby.those crystallizedin presence of PEG and PVP. Adsorption of the surfactant
or the water soluble polymer (pEG or PVP) on the crystal surface may possibly account for faster
dissolutionof the crystals.
One of the most important physical factor which
affects bio-availability and therapeutic efficacy of
a drug is the existence of active ingredient in
various crystal forms having different internal
structure and physiochemical properties). Many
solids may be prepared in a particular crystal form
via appropriate manipulation of conditions of
crystallization like nature of solvent, temperature,
rate of cooling etc. These .different crystal forms of
a given solid differ from each other with respect to
many physical properties such as solubility,
dissolution rate, true density crystal shape,
compaction behaviour and flow properties. A
physical form having improved solubility/dis-
solution rate is useful in improving bio-availability
of a drug from an immediate release drug delivery
system.
There are several reports on the existence of
various crystal forms in non-steroidal anti-
inflammatory drugs'" . However, literature is
largely silent on any such study on nimesulide.
Chemically, nimesulide (weak acid, pKa=6.S) is a
non-steroidal anti-inflammatory drug (NSAID) of
sulfonanilide class which is found to be clinically
effective in pain and inflammation associated with
a variety of conditions like arthritis, surgery,
cancer, gynaecological disorders etc 8. The basic
objective of the present investigation is to prepare
Nimesulide
different crystal forms of nimesulide with
improved dissolution characteristics.
Materials and Methods
Nimesulide (Pharmaceutical grade, 99.8%
purity)was obtained from Panacea Biotech Ltd.,
New Delhi(India). All solvents used were of AR
grade and obtained from S.D. Fine Chemicals Ltd.,
New Delhi. Tween 80 was obtained from G.S.C.
Industries, New Delhi. Povidone K30 (PVP) and
polyethyleneglycol 4000(PEG) were obtained from
Aurochem Laboratories; New Delhi and Wardex
Pharmaceuticals Ltd.,Sahibabad (India) respec-
tively.
IR spectra were recorded on FTIR Nicolet SDX
Infrared spectrophotometer. DSC was performed in
a Dupont Differential scanning calorimeter. X-ray
diffraction data was collected from Philips XRD
unit Model No. 1130/00 using proportional probe
scanning speed of lO/min. For melting point
studies, 'Scientific, digital melting point apparatus
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Table 1-Characteristics of nimesulide crystals obtained from Table II - Characteristics of nimesulide crystals preparedby
solvents or solvent mixtures solvent change
Crystal forms m.p. Solubility % Dissolvedlhr
from solvent (0C) (mgIL) (Mean±SE, n=3)
Acetone 146 60 25.37 ± 0.11
Chloroform 147 64 26.24 ± 0.11
Dichloromethane 146 66 30.46 ± 0.12
Methanol 148 66 32.84 ± 0.24
Acetonitrile 147 69 24.34 ± 0.25
Ethanol 147 71 41.59±0.34
Isopropanol 147 70 39.03 ± 0.40
Benzene 148 68 36.46 ± 0.33
CCI4 148 64 25.13±0.14
Ethyl acetate 147 64 22.67 ± 0.38
THF-Pet. ether 146 62 25.84 ± 0.09
Acetone - Water 148 62 29.72 ± 0.09
Parent Bulk 148 66 45.51±0.18
was used. Dissolution analysis was performed in
an V.S.P. dissolution apparatus with paddle type
stirrer. 'Toshniwal' shaker with water- bath was
used for solubility studies.
Preparation of nimesulide crystals
a) From various solvents. Drug (Ig) was
dissolved in sufficient volume of various
solvents/solvent mixtures. The solution was
filtered,concentrated and kept at room temperature
(25°C) to afford well defined crystals of
nimesulide(cf. Table-I). The crystals were
collected by filtration and dried under vaccum at
room temperature.
b) By solvent change (SC). Drug (1g) was
dissolved in 50 mL of solvent and filtered. The
filtrate was poured into 10 volumes of distilled
water (at 5°C). The crystals were collected by
filtration and dried under vaccum at room
temperature followed by exposure at 50°C for 24
hr.
c) By solvent cbange in presence of Tween 80
(SCT)lPovidone KJO (SCPVP)/polyethylenegly-
col 4000(SCPEG). Drug (1g) was dissolved in
30mL ethanol and the solution was filtered. To this
solution equal volume of distilled water (5°C)
containing either Tween 80 or PVP'K30 or PEG
4000 was added. The crystals so obtained were
filtered and subsequently dried under vaccum at
room temperature. The concentrations of Tween
80, PVP and PEG used in the study are shown in
Table II.
Solubility studies: Sample (20mg) (passed
Crystal forms from
Solvent change m.p. Solubility % Dissolvedlhr
(SC) eC) (mgIL) (Mean± SE, n=3)
Isopropanol 147 62 14.50 ± 0.30
Acetone 146 68 14.63 ± 0.33
Ethanol 146 58 17.42 ± 0.12
Acetonitrile 147 70 16.18±0.04
SCT(Tween)
0% 147 64 37.78 ± 0.29
0.5% 146 63 80.71 ± 0.08
1.0% 145 70 87.52 ± 0.28
1.5% 146 66 72.15 ± 0.30
2.0% 146 56 79.45 ± 0.25
2.5% 147 64 83.21 ± 0.40
SC (PVPIPEG)
PEG (2%) 148 64 53.56 ± 0.30
PEG (5%) 148 67 66.54 ± 0.29
PVP (2%) 147 63 51.21 ± 0.24
PVP(5%) 148 68 59.54± 0.34
through 100 mesh screen) was shaken with 25mL
phosphate buffer J.P. (PH 7.2) in a reciprocating
shaker (lOOshakes/minute) at 37°C for 8 hr. The
drug dissolved was analyzed spectrophoto-
metrically by measuring absorbance at 394nm.
Nimesulide is generally given by oral route where
the transit time of the drug through the
gastrointestinal tract is 8-12 hr. This means that if
the drug does not dissolve within 8 hr it will not be
absorbed. Considering the same, the solubility
studies were made for 8 hr.
Dissolution studies: 25 mg sample (passed
through 100 mesh screen) was added to 500 mL of
phosphate buffer, J.P. (PH 7.2), at 37°C in an
V.S.P. dissolution apparatus at 75 rpm. Samples
were withdrawn at suitable time intervals upto one
hour and amount of the drug dissolved was
determined as described earlier.The withdrawn
samples were replaced with equal volume of the
buffer.
Results and Discussion
The melting points, solubility and dissolution
rate of nimesulide crystals obtained from various
solvents or solvent mixtures are given in Table I.
Recrystallization of nimesulide resulted in de-
creased solubility and dissolution rate of most of
the crystals compared to parent bulk. Crystals from
ethanol and isopropanol (IPA) though showed
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higher solubility but the dissolution rate of each
was lower than parent bulk. Among the crystals
obtained from various solvents, crystals from
ethanol showed maximum dissolution rate
(4 1.59%/hr) folic-wed by those from IPA
(39.03%/hr, Table I). Crystals obtained by solvent
change method showed reduced dissolution rate as
compared to parent crystals. Crystallization of
nimesulide by solvent change (ethanol-water; 1:1)
in the presence of Tween 80 however, produced
crystals of higher dissolution rate and crystals from
1% Tween 80 showed lowest melting point, higher
solubility and fastest dissolution (87.52%/hr).
Similarly, nimesulide crystallized by solvent
change in the presence of water soluble polymers
like PEG (5%) and PVP (5%) produced crystals of
66.54% and 59.94% dissolution per hour
respectively (Table II). The results indicated
maximum dissolution rate for SCT (1%) crystals
followed by SCPEG (5%) and SCPVP (5%)
crystals whereas crystals from SCIP A had
minimum dissolution (Fig. 1). These crystals were
taken up for XRD, IR and DSC analysis. XRD
analysis (Fig 2) indicated that parent bulk had 9
number of 29 peaks having maximum intensity at
5.4° 29. In the SCIPA crystals, number of29 peaks
increased to 11 indicating increase in crystallinity
resulting in reduced dissolution. Similarly SCPEG
(5%) crystals had 8 number of 29 peaks which can
account for faster dissolution of these crystals. But
SCT (l %) crystals had 9, 29 peaks indicating no
change in crystallinity and the peak of maximum
intensity was at 5.6° 29. But these crystals
exhibited fastest dissolution. Similarly SCPVP
(5%) crystals had 11 number of 29 peaks (i.e.
increase in crystallinity compared to parent bulk)
but the crystals dissolved faster than parent bulk.
Thus we cannot explain the dissolution
characteristics of the crystals purely on the basis of
crystallinity. DSC analysis (Fig. 3) indicated
transition temperatures of 147.5, 148.4°C (melting
point) and heat of fusion (MIr) of 124 joules/g for
parent bulk. Rest of the crystals, except SCPEG
(5%) crystals, had single endothermic peak
indicating the absence of any solvates. SCPEG
(5%) crystals showed one endotherm at 56°C and a
melting endotherm at 148°C. The first endotherm
could be due to entrapment/adsorption of PEG











Figure 1 - Dissolution characteristics ofnimesulide crystal
forms
to melting point of PEG 4000 (55-57°C). The
melting point and heat of fusion (~Hr) of all the
crystals were lower than the parent bulk. SCPVP
(5%) crystals provided least ~Hr (l00 joules/g)
closely followed by SCPEG (5%) crystals (102
joules/g). Increased particle size (or decreased
surface area) usually decreases rate of thermal
reaction and increases transition temperature".
Thus minimum transition temperature (147 .5°C)
and heat of fusion of SCPVP (5%) crystals could
be due to smaller pariticle size resulting from
adsorption of PVP on the crystal surface. FTIR
spectra of SCPVP (5%) crystals showed an
additional peak compared to parent bulk and the
same supports the adsorption of PVP on the crystal
surface. Hence adsorption of a water soluble
polymer like PVP on the crystal surface could
possibly explain the faster dissolution of SCPVP
(5%) crystals though they were more crystalline
than the parent bulk. Crystallinity of SCT (1%)
crystals was same as that of parent bulk (as both
had same number of 29 peaks) but the crystals had
lower melting point(l47.8°C), lower heat of fusion
(~Hf = 122 joules/g) and higher dissolution rate
than the parent bulk. Enhanced dissolution rate of
chloramphenicol crystallized by solvent change
(ethanol-water; 1:1) in the presence of Tween 80
(2.5%) has been reported'" . Surfactant treatment
has been found to reduce the melting point of the
recrystallized chloramphenicol by 0.5-1.0°C.
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Figure 2 - X-ray diffraction patterns of various crystal forms
of nimesulide I. Parent Bulk, 2. SCIPA, 3. SCT(I%),
4. SCPVP(5%),5. SCPEG(5%)
Adsorption of surfactant on the crystal surface or
crystal defect leading to instability or solid
solution of the surfactant in the drug crystals has
been suggested as the likely mechanism for
enhanced dissolution. A similar mechanism may
also operate in case of surfactant treated crystals of
nimesulide [SCT (1%)] as the crystals showed
lower melting point and faster dissolution
compared to parent bulk. Thus on the basis of the
results obtained we may conclude that nimesuiide
crystals prepared by the solvent change in the
presence of Tween 80 [SCT (1%)] provide fastest
dissolution followed by SCPEG (5%) and SCPVP
(5%) crystals. Rapid dissolution of SCT (1%)
crystals is expected to provide faster absorption,
and further studies to support the same are in
progress.
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